至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Downregulating immunogenicity of Schwann cells via inhibiting a potential target of class II transactivator (CIITA) gene.

Biosci Trends. 2013; 
YangYi,DaiWenda,ChenZhengrong,YanZuoqin,YaoZhenjun,Zhan
Products/Services Used Details Operation
Nucleic Acid Purification & Analysis According to the recommendations of Ambion (Life Technologies) and Genscript (GenScript, PiscatawayNJ, USA) on the RNAi target sequence, ten pairs of DNA oligonucleotides were designed and synthesized for hairpin RNA expression by Sangon (Shanghai, China) (Table 1). Get A Quote

摘要

Immunological rejection induced by allogeneic Schwann cells remains a problem for construction of artificial nerves. Class II transactivator (CIITA) gene is a chief regulator of major histocompatibility complex class II (MHC II) molecules which contributes to the immunogenicity of Schwann cells. This study aimed to downregulate MHC II expression by suppressing CIITA expression, therefore reducing the immunogenicity of Schwann cells. Recombinant siRNA expression vectors targeting the CIITA gene were produced and subsequently transfected into rat RSC96 Schwann cells. Interferon (IFN)-γ was used to augment immunological rejection of RSC96 cells. The mRNA levels of CIITA and MHC II were assessed by fluorescence ... More

关键词